Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 100.86
(0.02%)
CNY 100.86
(0.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 327.45 Million CNY | 18.85% |
| 2022 | 259.26 Million CNY | 40.15% |
| 2021 | 184.99 Million CNY | 66.28% |
| 2020 | 111.25 Million CNY | 59.72% |
| 2019 | 69.65 Million CNY | 160.35% |
| 2018 | 26.75 Million CNY | 946.89% |
| 2017 | -3.15 Million CNY | 67.94% |
| 2016 | -9.85 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 113.31 Million CNY | 140.23% |
| 2024 Q2 | 118.72 Million CNY | 4.77% |
| 2023 Q1 | 86.72 Million CNY | 195.4% |
| 2023 FY | 308.13 Million CNY | 18.85% |
| 2023 Q4 | 47.17 Million CNY | -52.01% |
| 2023 Q3 | 98.3 Million CNY | 6.61% |
| 2023 Q2 | 92.2 Million CNY | 6.32% |
| 2022 FY | 259.26 Million CNY | 40.15% |
| 2022 Q4 | 29.35 Million CNY | -64.78% |
| 2022 Q3 | 83.35 Million CNY | 13.06% |
| 2022 Q2 | 73.72 Million CNY | 1.25% |
| 2022 Q1 | 72.81 Million CNY | 117.63% |
| 2021 Q1 | 40.09 Million CNY | 24.88% |
| 2021 Q3 | 49.99 Million CNY | -18.65% |
| 2021 Q2 | 61.44 Million CNY | 53.26% |
| 2021 Q4 | 33.45 Million CNY | -33.07% |
| 2021 FY | 184.99 Million CNY | 66.28% |
| 2020 Q3 | 34.75 Million CNY | -16.56% |
| 2020 Q1 | 2.73 Million CNY | -84.24% |
| 2020 FY | 111.25 Million CNY | 59.72% |
| 2020 Q4 | 32.1 Million CNY | -7.63% |
| 2020 Q2 | 41.65 Million CNY | 1421.53% |
| 2019 Q4 | 17.36 Million CNY | 40.36% |
| 2019 FY | 69.65 Million CNY | 160.35% |
| 2019 Q3 | 12.37 Million CNY | -41.46% |
| 2019 Q2 | 21.13 Million CNY | 12.61% |
| 2019 Q1 | 18.77 Million CNY | 245.92% |
| 2018 Q4 | 5.42 Million CNY | 0.0% |
| 2018 FY | 26.75 Million CNY | 946.89% |
| 2017 FY | -3.15 Million CNY | 67.94% |
| 2016 FY | -9.85 Million CNY | 0.0% |